HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹691 Cr | ₹828 Cr | ₹703 Cr | ₹653 Cr | ₹659 Cr |
What is the latest Total Current Liabilities ratio of HIKAL ?
Year | Total Current Liabilities |
---|---|
Mar2023 | ₹691 Cr |
Mar2022 | ₹828 Cr |
Mar2021 | ₹703 Cr |
Mar2020 | ₹653 Cr |
Mar2019 | ₹659 Cr |
How is Total Current Liabilities of HIKAL Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹691 Cr | -16.58 | |
Mar2022 | ₹828 Cr | 17.75 | |
Mar2021 | ₹703 Cr | 7.74 | |
Mar2020 | ₹653 Cr | -0.95 | |
Mar2019 | ₹659 Cr | - |
Compare Total Current Liabilities of peers of HIKAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
HIKAL | ₹3,667.6 Cr | -4.8% | 7.9% | 2.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
HIKAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
HIKAL | -4.8% |
7.9% |
2.4% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses